What Clinicians Need to Know About Oral Antivirals for COVID-19: An Expert Q&A
In this Q&A, Erica Johnson, MD, provides insight into the new oral antiviral medications that may soon be approved for the treatment of COVID-19.
Diagnosis & Disease Information
Risk Factors Associated With Vertical Transmission in Mothers With HIV Infection
Researchers sought to assess whether there is an association between maternal HIV drug resistance and an increased risk for vertical transmission and to describe the dynamics of drug resistance in infants with HIV infection.
U.S. Supply of COVID-19 Therapeutics Seems Stable, for Now
In September, as doctors prepared for a fall and winter COVID-19 surge across the U.S., they sounded alarms about inadequate supplies of the antiviral medication remdesivir to treat their patients. But that supply concern seems to have been addressed: Gilead, remdesivir’s U.S. manufacturer, confirmed that they are “meeting real-time, global demand” in an email to…
Hepatitis C Treatment Shows Impressive Results With New Three-Drug Combo Pill
Sofosbuvir, velpatasvir and voxilaprevir are used for patients who have failed with direct-acting antivirals.
- Loading...
Loading...
Loading... 
Loading...